ReviewBiomedicines2025

Targeting Diabetic Atherosclerosis: The Role of GLP-1 Receptor Agonists, SGLT2 Inhibitors, and Nonsteroidal Mineralocorticoid Receptor Antagonists in Vascular Protection and Disease Modulation.

Merita Rroji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.